Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Lawler

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Neuropharmacology|May 1, 1995
"Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implicationsJ H Gilmore, V J Watts, C P Lawler, et al.
Psychopharmacology|April 1, 1995
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptorsV J Watts, C P Lawler, D R Fox, et al.
Brain Research|August 6, 1999
Putative sigma(3) sites in mammalian brain have histamine H(1) receptor properties: evidence from ligand binding and distribution studies with the novel H(1) radioligand [(3)H]-(-)-trans-1-phenyl-3-aminotetralinR G Booth, C E Owens, R L Brown, et al.
European Journal of Pharmacology|September 28, 1993
Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodentsV J Watts, C P Lawler, J H Gilmore, et al.
Neuroscience|August 6, 1998
Behavioural assessment of mice lacking D1A dopamine receptorsD R Smith, C D Striplin, A M Geller, et al.
Journal of Medicinal Chemistry|March 12, 1999
Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quineloraneM K Doll, D E Nichols, J D Kilts, et al.
Synapse (New York, N.Y.)|October 1, 1995
Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonistsV J Watts, C P Lawler, A J Gonzales, et al.
European Journal of Pharmacology|August 3, 1993
Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligandsV J Watts, C P Lawler, T Knoerzer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypesC P Lawler, C Prioleau, M M Lewis, et al.
Journal of Neuroscience Methods|August 1, 1993
A rapid and efficient method for the radiosynthesis and purification of [125I]SCH23982C P Lawler, J H Gilmore, D H Mooney, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neuropharmacology|May 1, 1995
"Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implicationsJ H Gilmore, V J Watts, C P Lawler, et al.
Psychopharmacology|April 1, 1995
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptorsV J Watts, C P Lawler, D R Fox, et al.
Brain Research|August 6, 1999
Putative sigma(3) sites in mammalian brain have histamine H(1) receptor properties: evidence from ligand binding and distribution studies with the novel H(1) radioligand [(3)H]-(-)-trans-1-phenyl-3-aminotetralinR G Booth, C E Owens, R L Brown, et al.
European Journal of Pharmacology|September 28, 1993
Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodentsV J Watts, C P Lawler, J H Gilmore, et al.
Neuroscience|August 6, 1998
Behavioural assessment of mice lacking D1A dopamine receptorsD R Smith, C D Striplin, A M Geller, et al.
Journal of Medicinal Chemistry|March 12, 1999
Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quineloraneM K Doll, D E Nichols, J D Kilts, et al.
Synapse (New York, N.Y.)|October 1, 1995
Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonistsV J Watts, C P Lawler, A J Gonzales, et al.
European Journal of Pharmacology|August 3, 1993
Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligandsV J Watts, C P Lawler, T Knoerzer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypesC P Lawler, C Prioleau, M M Lewis, et al.
Journal of Neuroscience Methods|August 1, 1993
A rapid and efficient method for the radiosynthesis and purification of [125I]SCH23982C P Lawler, J H Gilmore, D H Mooney, et al.
Pageof 3